![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Stryker Receives FDA Clearance for 3D-Printed Tritanium C Anterior Cervical Cage
Stryker Receives FDA Clearance for 3D-Printed Tritanium C Anterior Cervical Cage
![Green_Light.gif](https://www.fdanews.com/ext/resources/test/Device_Images5/Green_Light.gif?t=1625610540&width=430)
September 22, 2017
Stryker’s received 510(k) clearance for its Tritanium C anterior cervical cage, a 3D printer interbody fusion cage for use in the cervical spine.
The device is constructed from Stryker’s proprietary Tritanium In-Growth Technology, a porous titanium material designed for bone in-growth and biological fixation. The device features an open central graft window and lateral windows to help reduce stiffness of the cage and minimize subsidence.
The device is indicated for use in cervical interbody fusion procedures in skeletally mature patients with degenerative disc disease.
Upcoming Events
-
21Oct